A detailed history of Trivant Custom Portfolio Group, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 120 shares of MRNA stock, worth $4,726. This represents 0.0% of its overall portfolio holdings.

Number of Shares
120
Holding current value
$4,726
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$63.64 - $125.14 $7,636 - $15,016
120 New
120 $8.02 Million
Q3 2023

Nov 02, 2023

SELL
$96.41 - $126.61 $867 - $1,139
-9 Reduced 0.09%
9,988 $1.03 Billion
Q2 2023

Jul 26, 2023

BUY
$118.5 - $160.53 $44,319 - $60,038
374 Added 3.89%
9,997 $1.21 Billion
Q1 2023

May 19, 2023

BUY
$135.66 - $197.02 $1.31 Million - $1.9 Million
9,623 New
9,623 $1.48 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Trivant Custom Portfolio Group, LLC Portfolio

Follow Trivant Custom Portfolio Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trivant Custom Portfolio Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trivant Custom Portfolio Group, LLC with notifications on news.